The effects of estrogens on atherosclerosis risk
| Project/Area Number |
18K16775
|
|---|
| Research Category |
Grant-in-Aid for Early-Career Scientists
|
| Allocation Type | Multi-year Fund |
|---|
| Review Section |
Basic Section 56040:Obstetrics and gynecology-related
|
|---|
| Research Institution | Kyoto Prefectural University of Medicine |
|---|
Principal Investigator |
Ito Fumitake 京都府立医科大学, 医学(系)研究科(研究院), 助教 (60756849)
|
|---|
| Project Period (FY) |
2018-04-01 – 2020-03-31
|
| Project Status |
Completed (Fiscal Year 2019)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2019: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2018: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | ホルモン補充療法 / 動脈硬化 / 接着因子 / エクイリン / エストラジオール / エストロゲン |
|---|
| Outline of Final Research Achievements |
To investigate the association between various estrogen types and atherosclerosis risk, we examined their effect on adhesion-molecule expression in human umbilical vein endothelial cells (HUVECs). In estrogen-treated HUVECs, the mRNA and protein expression levels of adhesion molecules were quantified by real-time polymerase chain reaction and enzyme immunoassay. Additionally, a flow-chamber system was used to assess the effects of estrogens on the adherence of U937 monocytoid cells to HUVECs. Equilin, but not 17β-estradiol (E2) or other types of estrogen, significantly increased the mRNA (P < 0.01) and protein (P < 0.05) expression of the adhesion molecules E-selectin and intercellular adhesion molecule-1 as compared with levels in controls.
|
| Academic Significance and Societal Importance of the Research Achievements |
閉経後女性における標準的なホルモン補充療法で使用されるCEEに含まれるEqが動脈硬化発症のリスクとなることが示唆され、天然型のE2はホルモン補充療法レジメンにより適していると考えられる。しかし、in vitroでの研究による限界も存在するため今後in vivoでの検討および大規模臨床試験による個別のエストロゲン製剤の作用効果につき検討が必要であると考えられた。
|
Report
(3 results)
Research Products
(15 results)
-
-
-
[Journal Article] Peroxisome proliferator-activated receptor-γ coactivator 1α-mediated pathway as a possible therapeutic target in endometriosis.2019
Author(s)
Kataoka H, Mori T, Okimura H, Matsushima H, Ito F, Koshiba A, Tanaka Y, Akiyama K, Maeda E, Sugahara T, Tarumi Y, Kusuki I, Khan KN, Kitawaki J.
-
Journal Title
Hum Reprod
Volume: 34
Issue: 6
Pages: 1019-1029
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis2018
Author(s)
Takaoka O, Mori T, Ito F, Okimura H, Kataoka H, Tanaka Y, Koshiba A, Kusuki I, Shigehiro S, Amami T, Kitawaki J
-
Journal Title
J Steroid Biochem Mol Biol
Volume: 181
Pages: 125-132
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
